About OncoLens
OncoLens is a company based in Atlanta (United States) founded in 2015 by Anju Mathew. OncoLens has raised $27.1 million across 4 funding rounds from investors including Atlanta Technology Angels, BIP Ventures and Cross-Border Impact Ventures. The company has 35 employees. OncoLens offers products and services including OncoLens Platform, Molecular Store, Integrate Module, and Collaborate Module. OncoLens operates in a competitive market with competitors including Medshr, F6S Network, Omnidoc, Liangyihui and Curofy, among others.
- Headquarter Atlanta, United States
- Employees 35
- Founders Anju Mathew
- SectorsHealthcare
- Email••••••••
- Website oncolens.com
- Social LinkedIn X Facebook
- Legal Name Lynkcare, Inc.
- Total Equity Funding$27.1 M (USD)
in 4 rounds
- Latest Funding Round$16 M (USD), Series B
Oct 02, 2024
- InvestorsAtlanta Technology Angels
& 4 more
- Employee Count35
People of OncoLens
21 people are tracked at OncoLens (12 in leadership, 7 in board & advisors, 2 in team); the tracked headcount is 35.
| Name | Role | Group |
|---|---|---|
Anju Mathew | Co-Founder & CEO | Leadership |
Keith Anderson | Director of Talent | Leadership |
Heather Creran | COO | Leadership |
Lijo Simpson | Co-Founder & Chief Medical Officer | Leadership |
Leslie Smith Marshall | Director Of Product | Leadership |
Chace Herndon | VP, Business Development, Provider Solutions | Leadership |
Michelle Lu | Director Of Product, Life Sciences | Leadership |
James Noe | VP Of Business Development, Life Sciences | Leadership |
Daniela Davies Ordiway | Director Of Enablement | Leadership |
Tom Sims | Director Of Business Development | Leadership |
Jeremy Stapp | Senior Director, Oncology Strategy | Leadership |
Robert Wojciechowski | VP, Engineering | Leadership |
Mark Buffington | Board Member | Board & advisors |
Devin Carty | Board Member | Board & advisors |
Elder Granger | Advisor | Board & advisors |
Shantanu Nigam | Board Member | Board & advisors |
Timothy Mullett | Advisor | Board & advisors |
Kishore Kumar | Advisor | Board & advisors |
Jane McCracken | Advisor | Board & advisors |
Lori Miller | Senior Product Manager | Team |
1 more people are available in the full profile.
Complete people profiles for OncoLens
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Products & Services of OncoLens
OncoLens offers a comprehensive portfolio of products and services, including OncoLens Platform, Molecular Store, Integrate Module, and Collaborate Module.
Integrates data for precise cancer treatment and collaboration
Stores biomarkers for research and treatment recommendations
Connects EMR systems for real-time patient information
Enables real-time team discussions on cancer cases
Funding Insights of OncoLens
OncoLens has successfully raised a total of $27.1M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $16 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $27.1M
- Total Rounds 4
- Last Round Series B — $16.0M
- First Round $1.4M
(26 Mar 2019)
- Investors Count 5
All 4 funding rounds of OncoLens with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| 02 Oct 2024 | $16.0M | Series B | – | BIP Ventures , Cross Border Impact Ventures | |
| 13 Jan 2021 | $7.2M | Series A | – | Martin Ventures , BIP Ventures | – |
| 06 Jan 2020 | $2.5M | Seed | – | BIP Ventures | |
| 26 Mar 2019 | $1.4M | Seed | – | Atlanta Technology Angels , BIP Ventures | – |
5 investors in total: 5 institutional.
Investors in OncoLens
OncoLens has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Atlanta Technology Angels, BIP Ventures and Cross-Border Impact Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investments are provided by BIP Ventures. | – | bipventures.vc | Atlanta, United States | |
Investments are focused on health technology for global impact. | – | crossborder.ventures | Toronto, Canada | |
Early-stage tech focused VC firm investing in geographies such as the US | – | martinventures.com | Nashville, United States | |
Angel investments are provided across Atlanta and Georgia. | 1998 | angelatlanta.com | Atlanta, United States | |
Invests in Seed and Series A AI healthcare startups with network and tactical support. | 2020 | seedtob.com | Canada |
Investor details for OncoLens
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of OncoLens
3 dated milestones of OncoLens across 9 years, from founding to its latest funding, stage changes and deals.
- Founded OncoLens is founded.
- Funding First funding round of $1.4M.
- Funding Latest funding round, Series B, of $16.0M.
Competitors of OncoLens
OncoLens operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medshr, F6S Network, Omnidoc, Liangyihui and Curofy, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| medshr.net | 2013 | London, United Kingdom | $1.9M | 13 | Knowledge sharing platform for Physicians | |
| f6s.com | 2005 | London, United Kingdom | $1.2M | 26 | Provider of platforms for startups to find investors, talent and other resources | |
| omnidoc.fr | 2018 | Paris, France | $10.0M | – | Provider of social discussion platform for physicians | |
| liangyihui.net | 2015 | Shanghai, China | $17.1M | – | Medical information platform for cancer | |
| curofy.com | 2014 | Gurugram, India | $1.9M | 101 | Online network for doctors' communication and patient referrals is provided. | |
| qtclinics.com | 2014 | Palo Alto, United States | $7.4M | – | Platform to provide cancer-related information & second opinion | |
| oathcare.com | 2019 | San Francisco, United States | $8.0M | – | Offers a professional network and monitoring platform for healthcare providers focused on pregnancy and pediatrics. | |
| yinglink.com | 2016 | Beijing, China | $6.1M | – | A collaboration platform for healthcare providers in China is offered. |
Detailed competitors of OncoLens
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Oncolens
Complete news archive for OncoLens
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Similar companies to OncoLens
10 companies that operate in the same segment as OncoLens (Clinical IT & Data Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts | 2016 | Bengaluru, Karnataka, India | USD 713.57 M | – | – | |
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | – | – | |
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 233 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | – | – | |
Tech-enabled mental health solutions for employers are provided. | 2016 | New York, New York, United States | USD 508.73 M | – | – | |
App-based health insurance is offered to individuals and businesses. | 2016 | Paris, France | USD 863.12 M | – | – | |
Virtual care programs for managing chronic diseases are provided. | 2011 | San Francisco, California, United States | USD 450.12 M | USD 260.21 M | – | |
AI-driven EMR and practice management software is delivered for clinics. | 2010 | Boca Raton, Florida, United States | USD 329.17 M | – | – | |
Cloud-based administrative tools for healthcare providers are offered. | 1997 | Watertown, United States | USD 40 M | – | – | |
Membership-based primary care platform is offered for employees and consumers. | 2007 | San Francisco, California, United States | USD 402.56 M | – | – |
Frequently Asked Questions about OncoLens
OncoLens was founded in 2015 and raised its 1st funding round 4 years after it was founded.
OncoLens is headquartered in Atlanta, United States. It is registered at Atlanta, Georgia, United States.
Anju Mathew is the current CEO of OncoLens. They have also founded this company.
OncoLens is a funded company, having raised a total of $27.1M across 4 funding rounds to date. The company's 1st funding round was a Seed of $1.35M, raised on Mar 26, 2019.
OncoLens has 35 employees.
OncoLens is a HIPAA compliant mobile and web-based platform for connecting oncologists. The platform enables physicians to create a tumor board and also allows them and other care providers to discuss and develop treatment plans for their cancer patients in real-time. OncoLens also enables the discussion of cases among colleagues and care teams without the involvement of a tumor board. Through the engagement of clinical trial researchers, cases can be identified early on as potential candidates for clinical trials.
OncoLens's top competitors include F6S Network, Curofy and Medshr.
OncoLens offers OncoLens Platform, Molecular Store, Integrate Module, and Collaborate Module.
OncoLens has 5 investors. Key investors include Atlanta Technology Angels, BIP Ventures, Cross-Border Impact Ventures, Martin Ventures, and seedToB.
OncoLens operates through Lynkcare, Inc..